Caffeine 2ml x10 Ampoules - Reducing - Active ingredients mesotherapy microneedling

CAFFEINE AMPOULES
Lipolytic Solution

The action of caffeine drains the body's fat cells; in other words, it speeds up circulation and stimulates the release of fats accumulated in adipocytes, so they can be burned by the body's own metabolism. Furthermore, the Caffeine Reducing Solution firms and tones the skin, helping to reduce the appearance of cellulite. When applied topically, it acts as a lipolytic agent, destroying fatty tissue and causing localized weight loss without side effects.

NON-INJECTABLE

Caffeine Ampoules 10%, 2 ml, 10 units. Sterile solution. Active ingredient for aesthetics

Indications: The action of caffeine speeds up circulation and stimulates the release of fats accumulated in adipocytes, so they can be burned by the body's own metabolism. In simple terms, the Caffeine Reducing Solution drains the body's fat cells. Additionally, the Caffeine Reducing Solution firms and tones the skin, helping to reduce the appearance of cellulite. When applied topically, it acts as a lipolytic agent, destroying fatty tissue and causing localized weight loss without incurring side effects.

Active ingredient: Caffeine

Directions for use: Suitable for the most advanced application techniques that combine traditional mesotherapy with the most advanced transdermal delivery systems: Skin rollers, galvanic currents (iontophoresis, hydroelectroforese), ultrasound (sonophoresis), IR thermotherapy (cathophoresis), electromagnetic waves (electroporation), cryoelectroforesis, and vacuum therapies.

Presentation: Box with 10 ampoules of 2 ml.

Product indicated for: Meso Roller, Meso Pen, galvanic currents (iontophoresis, hydroelectroforese), radiofrequency, ultrasound (sonophoresis), IR thermotherapy (cathophoresis), electromagnetic waves (electroporation), cryoelectroforesis, and vacuum therapy. Non-Injection

ATTENTION
For hygiene reasons, health risks, and product stability, this item is non-returnable, in accordance with Article 103 of the Royal Legislative Decree 1/2007 (Spanish regulations) and Directive 2011/83/EU of the European Parliament.